News
Check Point Software Technologies has announced updates to its Quantum Force Security Gateways, introducing both performance ...
The Lao government is partnering with the private sector to conduct a feasibility study for a major expressway project ...
Bloomberg reported that Bristol-Myers Squibb Company (NYSE:BMY) and BioNTech SE (NASDAQ:BNTX) announced a strategic licensing ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
A study has revealed why some patients don’t respond to immune checkpoint blockade (ICB) therapy for solid cancer tumours and ...
Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...
“Government and military organisations continue to take the brunt of cyber-criminal activities,” says Lorna Hardie, Regional Director: Africa for Check Point Software.
Securing re-entry tags now can help assure a smooth post-hurricane return for Manatee County barrier island if a storm hits this season.
Global mRNA Cancer Vaccines Clinical Trials, Market Trends By Indication, Development Priority Status and Market Opportunity ...
Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring (TRM), a liquid biopsy assay ...
7h
News Medical on MSNNew Therapy Targets Resistant Skin CancersA study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumours and identifies a new ...
The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results